AstraZeneca, Valeant, Mattel Downgraded

AstraZeneca, Valeant, and Mattel stocks received bearish analyst attention

Apr 21, 2017 at 9:58 AM
facebook X logo linkedin


Analysts are weighing in on drugmakers AstraZeneca plc (ADR) (NYSE:AZN) and Valeant Pharmaceuticals Intl Inc (NYSE:VRX), as well as toy stock Mattel, Inc. (NASDAQ:MAT). Here's a quick roundup of today's bearish brokerage notes on shares of AZN, VRX, and MAT.

AstraZeneca Stock Slips on Reduced Price Target

AZN saw its price target cut to 4,900P from 5,050P at Jefferies. Out of the gate, the stock is down 0.3% at $29.82, as its struggles since a late-March top near $32 continue. Things could get even more interesting for AstraZeneca plc next week, with the company due to report earnings early Thursday. One group that can't be happy with the shares' recent losses is options traders. During the past 50 days at the International Securities Exchange (ISE), Chicago Board Options Exchange (CBOE), and NASDAQ OMX PHLX (PHLX), AZN stock has amassed a call/put volume ratio of 12.17 -- just 7 percentage points from an annual peak.

Valeant Stock Hit With Another Bearish Note

For the second straight day, VRX stock is dealing with bearish attention from analysts. Specifically, Wells Fargo reiterated an "underperform" rating, and offered a valuation range of $7-$9 -- in line with where the shares are trading, down 0.5% at $8.84. Overall, Valeant Pharmaceuticals Intl Inc has had a horrid time on the charts, shedding three-quarters of its value year-over-year. This helps explain why nearly 46 million shares are sold short -- a lofty 15% of VRX's float. Separately, the drugmaker announced pricing information on plaque psoriasis treatment Siliq.

Mattel Earnings Pressure Stock to New Lows

MAT stock earlier sunk to an annual low of $22.72, and was last seen down 9.5% at $22.81, after a wider-than-expected first-quarter loss and gloomy full-year sales forecast. The downbeat earnings report provoked price-target cuts at no fewer than four analysts -- including SunTrust Robinson, which lowered its target to $25 from $28, explaining, "It could be at least another few quarters before we have any sense that the ship can begin to turn in 2017/2018." The sell-off is surely welcomed by short-term MAT options traders, who have favored puts over calls, relatively speaking. Mattel, Inc. sports a Schaeffer's put/call open interest ratio (SOIR) of 0.88, outstripping 88% of readings from the last 12 months.

 

Target Effortless Triple-Digit Gains Every Sunday Evening For Life!

This is your chance to triple your profit potential on Sunday evenings, without spending all your free time watching the market.

On Sundays, as a Weekend Plus subscriber, you’ll get up to 6 trades every Sunday, each targeting gains of 200% or more.

Start targeting gains like the ones our subscribers have seen recently, including:

213.3% GAIN on AutoNation calls
100.0% GAIN on Monster Beverage calls
100.4% GAIN on Walgreens Boots Alliance puts
100.4% GAIN on ON Semiconductor calls
257.7% GAIN on Dell calls

101.0% GAIN on Apollo Global Management calls
103.6% GAIN on JP Morgan  Chase calls
105.3% GAIN on DraftKings calls
101.3% GAIN on Airbnb calls
203.0% GAIN on Shopify calls
102.0% GAIN on Cboe Global Markets calls
100.9% GAIN on Boeing calls
102.1% GAIN on Microsoft puts
102.3% GAIN on First Solar calls
101.5% GAIN on PulteGroup calls
101.0% GAIN on Apple calls
209.4% GAIN on NXP Semiconductors calls
100.8% GAIN on Uber Technologies calls
100.4% GAIN on Academy Sports and Outdoors puts
102.2% GAIN on Trade Desk calls
100.8% GAIN on DoorDash calls
100.0% GAIN on Camping World Holdings puts
100.0% GAIN on Cboe Global Markets calls
100.2% GAIN on C3.ai calls
238.5% GAIN on Oracle calls

 
 
 


 
 

Rainmaker Ads CGI